FDA Inspection 986262 — Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd. on Jun 30, 2016 in Shijiazhuang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2016
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Shijiazhuang (China)